Showing 1 - 3 results of 3 for search 'M. Arnan Sangerman', query time: 0.02s
Refine Results
-
1
P586: IADADEMSTAT COMBINATION WITH AZACITIDINE SHOWS ENCOURAGING SAFETY AND EFFICACY DATA IN ELDERLY AND UNFIT AML PATIENTS by O. Salamero, T. Somervaille, A. Molero, E. Acuña-Cruz, J. A. Perez-Simon, R. Coll, M. Arnan Sangerman, B. Merchan, A. Perez, I. Cano, R. Rodriguez-Veiga, M. Arevalo, S. Gutierrez, C. Buesa, F. Bosch, P. Montesinos
Published 2022-06-01
Article -
2
P568: REAL-LIFE EXPERIENCE OF TREATMENT REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS WITH VENETOCLAX COMBINATION THERAPY by H. Pomares Marin, J. Villarreal Hernández, M. Condom Esteve, S. Vives Polo, M. Cervera Calvo, R. Coll Jorda, C. Maluquer Artigal, G. Ibarra Fernández, A. Torrent Catarineu, M. Galiano Barajas, A. M. Sureda Balari, M. Arnan Sangerman
Published 2022-06-01
Article -
3
P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTATED AML. “REAL LIFE” DATA VERSUS THE RATIFY STUDY by A. De La Fuente, M. Diaz Beya, P. Beneit, C. Botella, A. Fernandez Moreno, A. Sampol, M. Arnan Sangerman, A. Yeguas Bermejo, M. D. L. L. Amigo, J. Labrador, A. Garcia Guinon, A. Garrido, J. Serrano, S. Vives Polo, M. Garcia Fortes, M. J. Sayas, J. M. Bergua, M. T. Olave, F. Vall LLovera, J. Bargay, M. Pereiro Sanchez, R. Garcia Boyero, A. Diaz Lopez, M. Tormo
Published 2022-06-01
Article